Methylphenidate is a stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD) and certain ...

An open platform called GPCRmd-NMR combines molecular dynamics simulations with NMR spectroscopy to expose hidden ...

The FDA has approved Brytly (apraclonidine ophthalmic solution 0.125%) as an over-the-counter treatment for minor eye redness ...

The new research, published in ERJ Open Research, found that nearly one in five asthma patients and one in three COPD ...

BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with ...

The FDA just approved Brytly, a nonprescription apraclonidine eye drop for red eyes. A doctor explains its use and potential ...

TONMYA improved Fibromyalgia Impact Questionnaire-Revised (FIQR) symptoms and function scores versus placebo in both domains at Week 14 in RELIEF ...

The medicine approved by AIFA complements auto-injectors: needle-free and just as effective, it is a life-saving treatment ...

A new review finds that recipient factors such as durable LVAD support, amiodarone exposure, renal dysfunction and prior ...

Indenol and methylphenidate are prescription medications used for cardiovascular disease and attention-deficit hyperactivity ...

BXCL501, a dexmedetomidine sublingual film, is under FDA review for first-ever at-home use for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adultsAcqui ...

Neurocrine Biosciences, Inc.  (Nasdaq: NBIX) today announced new research that helps define clinically meaningful improvement in overall health reported by people living with tardive dyskinesia who ...